Insights - A recording of our October Healthcare Huddle is now available. Unfortunately, SOMEONE forgot to record the actual webinar last night, so we re-recorded it this … Continue Reading
Premium: Read NowInsights - Drug stocks tumbled across the board on Wednesday with Hillary Clinton’s latest jab at the industry, spurred by the current backlash against EpiPen-maker, Mylan (MYL). … Continue Reading
Read NowInsights - After a tumultuous and breathtaking plunge earlier this week, equities have rebounded in a big way. That’s quite constructive. The UK’s vote to leave the EU … Continue Reading
Premium: Read NowInsights - Market Participant Love Strawman Issues
Read NowInsights - Rockwell Medical (RMTI) reported sales of Triferic in the first quarter of … none. Rockwell sold $200K worth of Triferic in the fourth quarter of … Continue Reading
Read NowInsights - With three pieces of M&A news on Thursday morning, and a mixed bag of earnings from large bio/pharma companies so far this week, investors will see what they want … Continue Reading
Read NowInsights - Vericel Corp (VCEL) cratered on Monday with details from a phase 2b study of its ixmyelocel-T cell therapy for heart failure, presented at the American College … Continue Reading
Read Now
